Results 91 to 100 of about 24,700 (204)
Transfusion, EarlyView.Abstract Background The aim of this study was to investigate a CD34 expression assay as an additional tool for the total nucleated cell (TNC) count assessment in bone marrow harvest (BMH) obtained from healthy donors. Study Design and Methods Samples obtained from bone marrow donors (n = 71) were analyzed for CD34 expression using a digital PCR assay ...
Miguel Waterhouse +13 more
wiley +1 more source
Transfusion, EarlyView.Abstract Background Allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment primarily for hematological malignancies. Infections, relapse, and graft versus host disease (GvHD) are some of the most common adverse events following HSCT. We aimed to evaluate whether the lymphocyte function of the stem cell graft was associated with these ...
Anna Söderström +8 more
wiley +1 more source
Post-dengue fever severe aplastic anemia: a rare association
Hematology/Oncology and Stem Cell Therapy, 2012 Dengue fever has rarely been reported as an etiology for aplastic anemia. An 8-year-old girl was admitted with fever, myalgia and petechiae. Dengue virus IgM antibodies were positive. she recovered completely, but her thrombocytopenia persisted.
Mohammed Ramzan +2 more
doaj +1 more source
Transfusion, EarlyView.Abstract Background Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic stem cell disorder caused by somatic mutations in the PIGA gene, resulting in loss of glycosylphosphatidylinositol (GPI)‐anchored proteins, including the complement regulatory proteins, CD55 and CD59.
Ganesh Raman +4 more
wiley +1 more source
Transfusion, EarlyView.Abstract Background Newly positive hepatitis B virus (HBV) serologic results after allogeneic hematopoietic cell transplantation (HCT) may reflect passive antibody transfer from blood‐derived products rather than HBV infection. We investigated the incidence and temporal patterns of hepatitis B surface antibody (anti‐HBs) and antibody to hepatitis B ...
Takaaki Konuma +7 more
wiley +1 more source
Vox Sanguinis, EarlyView.Abstract Background and Objectives Parvovirus B19 (B19V) testing is often not required to release blood components. However, the European Pharmacopoeia requires that plasma pools for fractionation contain no more than 104 IU/mL of B19V DNA. In France, pool B19 nucleic acid testing (NAT) screening was performed by Établissement Français du Sang since ...
Virginie de la Taille +12 more
wiley +1 more source
Analytical Science Advances, Volume 7, Issue 2, December 2026.Nanosensor schematic functionalized with specific bioreceptors that produce electrochemical signals upon Chloramphenicol binding. Resulting voltammetric readouts (differential pulse, square‐wave, and cyclic voltammetry) are analyzed to identify and quantify Chloramphenicol.
Nava Moghadasian Niaki +5 more
wiley +1 more source
SLE Complicated With AIHA and Parvovirus B19 Infection Secondary to PRCA: A Case Report
Clinical Case Reports, Volume 14, Issue 11, November 2026.We report the diagnosis and treatment process of a female with SLE and AIHA infected with parvovirus B19 and secondary PRCA. Interestingly, there was no significant increase in hemoglobin after IVIG treatment for more than 50 days; however, the addition of foscarnet showed good efficacy.
Mingquan Xing +4 more
wiley +1 more source
Acute Promyelocytic Leukemia With PML‐RARA Rearrangement: Clinical and Morphologic Features
Clinical Case Reports, Volume 14, Issue 11, November 2026.ABSTRACT Recognition of the characteristic morphologic features of acute promyelocytic leukemia on peripheral blood smear should prompt immediate initiation of all‐trans retinoic acid while awaiting confirmatory testing, as early intervention is critical to reducing hemorrhagic mortality and improving clinical outcomes.
Chukwuka Elendu +2 more
wiley +1 more source
Management of aplastic anemia [PDF]
European Journal of Haematology, 1991 C, Nissen, A, Gratwohl, B, Speck
openaire +2 more sources